CLSA Reiterates Sell (5) Rating on Glenmark Pharmaceuticals Ltd. (GNP:IN)

February 17, 2021 1:03 AM EST
Get Alerts GNP:IN Hot Sheet
Price: $0.00 --0%


Trade Now! 
Join SI Premium – FREE

CLSA analyst Akok Dalal reiterated a Sell (5) rating and INR490.00 price target on Glenmark Pharmaceuticals Ltd. (GNP:IN).


You May Also Be Interested In





Related Categories

Intl Ratings